CST3 and kidney disorder: Previously we have shown that a four-biomarker model of soluble tumour necrosis factor receptor-1 and -2 (sTNFR1, sTNFR2), cystatin C and estimated glomerular filtration rate (eGFR) measured 90 days after AKI performed well in predicting subsequent kidney disease progression.